Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Roles of Military Health Diplomacy and Health Security When Conducting Global Health Engagements That Primarily Promote National Security.

Developing world bioethics·2026
Same author

Antibiotics in Tactical Combat Casualty Care 2025: TCCC Change 25-1.

Journal of special operations medicine : a peer reviewed journal for SOF medical professionals·2025
Same author

Oral vs Intravenous Antibiotics for Fracture-Related Infections: The POvIV Randomized Clinical Trial.

JAMA surgery·2025
Same author

Do the results of the OXYGEN trial change if analyzed as "as-treated?": A secondary analysis of the OXYGEN trial.

Injury·2024
Same author

Does Topical Vancomycin Powder Use in Fracture Surgery Change Bacteriology and Antibiotic Susceptibilities? An Analysis of the VANCO Trial.

Journal of orthopaedic trauma·2024
Same author

Seasonality of Microbiology of Combat-Related Wounds and Wound Infections in Afghanistan.

Military medicine·2023

Related Experiment Videos

Acinetobacter infection in the ICU.

Clinton K Murray1, Duane R Hospenthal

  • 1Infectious Disease Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA. clinton.murray@amedd.army.mil

Critical Care Clinics
|March 26, 2008
PubMed
Summary

Acinetobacter infections pose a significant threat to critically ill patients due to rapid antimicrobial resistance. Effective management may rely on infection control and antibiotic stewardship, rather than dual therapy, to combat these challenging bacteria.

Related Experiment Videos

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Acinetobacter poses a significant challenge in managing critically ill patients.
  • Rapid development of antimicrobial resistance by Acinetobacter is a growing concern.
  • Increasing data link Acinetobacter infections to mortality in hospitalized patients with comorbidities.

Purpose of the Study:

  • To evaluate the current understanding of Acinetobacter management in critically ill patients.
  • To assess the role and potential drawbacks of dual antimicrobial therapy.
  • To highlight effective strategies for controlling Acinetobacter infections.

Main Methods:

  • Review of current literature on Acinetobacter infections and antimicrobial resistance.
  • Analysis of the evidence regarding dual therapy efficacy and toxicity.
  • Evaluation of infection control and antibiotic stewardship practices.

Main Results:

  • Acinetobacter's rapid antimicrobial resistance development is a major clinical challenge.
  • The role of dual therapy is unclear, potentially increasing toxicity without proven benefit.
  • Infection control and antibiotic stewardship appear crucial for managing Acinetobacter.

Conclusions:

  • Infection control and antibiotic stewardship are likely the most impactful strategies against Acinetobacter.
  • Further research is needed to develop new antimicrobial agents.
  • Optimal use of existing antimicrobial agents requires further assessment.